HIGHLIGHTS
- who: Chenzheng Gu and colleagues from the Department of Laboratory Medicine, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, China have published the Article: NCOA4: An Immunomodulation-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer, in the Journal: Journal of Oncology of 16/06/2022
- what: The aim of this study was to determine the relationship between NCOA4 expression and prognosis and patient survival. This work conducted a comprehensive analysis of NCOA4 expression in a pan-cancer dataset for the first time.
- how: In this work TCGA GEPIA and several bioinformatics . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.